Publications of Stephan Ripke
All genres
Journal Article (34)
2013
Journal Article
: Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. NATURE GENETICS 45 (9), pp. 984 - 994 (2013)
Journal Article
: Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels. EUROPEAN NEUROPSYCHOPHARMACOLOGY 23 (7), pp. 653 - 662 (2013)
2011
Journal Article
: Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genetics 43 (10), pp. 977 - 983 (2011)
Journal Article
: TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry 16 (6), pp. 647 - 663 (2011)
Journal Article
: The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 70, pp. 252 - 265 (2011)
2010
Journal Article
: Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 15 (7), pp. 736 - 747 (2010)
2009
Journal Article
: Polymorphisms in the GAD2 Gene-Region Are Associated With Susceptibility for Unipolar Depression and With a Risk Factor for Anxiety Disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 150B (8), pp. 1100 - 1109 (2009)
Journal Article
: Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 73, pp. 665 - 666 (2009)
Journal Article
: A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 66 (9), pp. 966 - 975 (2009)
Journal Article
: A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 42 (5), p. 224 - 224 (2009)
Journal Article
: Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 42 (5), p. 226 - 226 (2009)
Journal Article
: The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 42 (5), p. 230 - 230 (2009)
Journal Article
: Polymorphisms in the gene encoding the neuropeptide galanin are associated with HPA-axis dysregulation and symptome severity in major-depressive- and anxiety-disorder patients. Pharmacopsychiatry 42 (5), p. 244 - 244 (2009)
Journal Article
: Novel Genetic Risk Markers for Ulcerative Colitis in the IL2/IL21 Region Are in Epistasis With IL23R and Suggest a Common Genetic Background for Ulcerative Colitis and Celiac Disease. American Journal of Gastroenterology 104 (7), pp. 1737 - 1744 (2009)
Journal Article
: The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. Journal of Neural Transmission 116 (6), pp. 649 - 657 (2009)
Journal Article
40 (3), pp. 970 - 972 (2009)
Genetic Variation in the Lymphotoxin-Alpha Pathway and the Risk of Ischemic Stroke in European Populations. Stroke
Journal Article
: Polymorphisms in the Angiotensin-Converting Enzyme Gene Region Predict Coping Styles in Healthy Adults and Depressed Patients. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 150B (1), pp. 104 - 114 (2009)
2008
Journal Article
: Evidence for associations between PDE4D polymorphisms and a subtype of neuroticism. Molecular Psychiatry 13 (9), pp. 831 - 832 (2008)
Journal Article
: PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nature Genetics 40 (8), pp. 946 - 948 (2008)
Journal Article
: Association of GRIK4 and 5-HTR2A with antidepressant treatment in the MARS cohort of depressed impatients. International Journal of Neuropsychopharmacology 11 (Suppl. 1), pp. 112 - 113 (2008)